Press & Media Centre – pcc1.news
Official press information for pcc1.news and the 199 group.
Welcome to the official press page for pcc1.news, the news and research arm of the 199 group. Here you will find authoritative background information on our founder, a record of featured media coverage and clear contact details for interview or comment requests.
Contact for journalists
Email support@pcc1.news
Postal address: 199 Longevity Ltd, 199 Gloucester Terrace, London W2 6LD, United Kingdom
About the founder
Boris Djordjevic – CEO, Founder, Investor
Boris Djordjevic established the 199 group of companies to accelerate translational longevity science.
- 199 Biotechnologies Ltd develops partial cellular re-programming and epigenetic therapies aimed at reversing ageing and treating aggressive cancers such as glioblastoma.
- 199 Clinic Ltd and London Longevity Clinic Ltd deliver accessible preventive medicine and concierge longevity services.
- 199 Diagnostics offers advanced tests—including AgeQuant™ NAD⁺-metabolism kits and micro-plastics exposure assessments—while 199 Health develops patent-pending nutraceuticals that feature Procyanidin C1 (PCC1) in novel phytosomal delivery formats.
An active investor and futurist, Boris focuses on innovations that will reshape human health, biotechnology and extended lifespan.
Selected media coverage
- Longevity.Technology – interview: "Yamanaka factors are a biological cheat code" (profile of 199 Biotechnologies and CEO Boris Djordjevic) (Longevity Technology)
- EurekAlert! – press announcement: "199 Biotechnologies to sponsor ARDD 2024, the world's largest conference on ageing research" (EurekAlert!)
- Aging Research & Drug Discovery Meeting (ARDD) – Speakers list 2024 – Boris Djordjevic featured as conference speaker on epigenetic therapeutics (ARDD 2025)
- Live Forever Club – company profile: 199 Biotechnologies recognised as a leading rejuvenation-therapy developer (Live Forever Club)
For additional quotes or background materials, please email the press contact above.
Trademarks
PCC1™ and 199™ are registered trademarks or trademarks of 199 Longevity Ltd in the United Kingdom and other jurisdictions. All other marks belong to their respective owners.
High-resolution logos, executive photographs (including a studio portrait of Boris Djordjevic) and brand-usage guidelines are available on request.